No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
AYTU Aytu BioPharma
- 3.2700
- +0.0600+1.87%
Close May 10 16:00 ET
- 3.2400
- -0.0300-0.92%
Post 16:00 ET
18.21MMarket Cap-815P/E (TTM)
3.2700High3.1742Low15.21KVolume3.2200Open3.2100Pre Close49.14KTurnover0.40%Turnover RatioLossP/E (Static)5.57MShares3.500052wk High0.55P/B12.42MFloat Cap1.380052wk Low--Dividend TTM3.80MShs Float27279.9864Historical High--Div YieldTTM2.98%Amplitude1.3800Historical Low3.2300Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Aytu BioPharma to Report Third Quarter Fiscal 2024 Financial and Operational Results on May 15, 2024
323 drugs, hurry up! America is facing the biggest “drug shortage” in history...
The US now seems to be facing an unprecedented “drug shortage”...
Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
Aytu BioPharma Second Quarter 2024 Earnings: Beats Expectations
Earnings Call: Aytu BioPharma Achieves First Positive Operating Income
Q2 2024 Aytu Biopharma Inc Earnings Call
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg